Epigenetic therapy to enhance therapeutic effects of PD-1 inhibition in therapy-resistant melanoma.

Sah, Vasu R; Karlsson, Joakim; Jespersen, Henrik; Lindberg, Mattias F; Nilsson, Lisa M; Ny, Lars; Nilsson, Jonas A

Sah, Vasu R; Karlsson, Joakim; Jespersen, Henrik; Lindberg, Mattias F; Nilsson, Lisa M; Ny, Lars; Nilsson, Jonas A.

Affiliation

Sah VR; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Center for Cancer Research, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden.
Karlsson J; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Center for Cancer Research, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden.
Jespersen H; Harry Perkins Institute of Medical Research, University of Western Australia, Perth, Australia.
Lindberg MF; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Center for Cancer Research, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden.
Nilsson LM; Department of Oncology, Akershus University Hospital, Lørenskog, Norway.
Ny L; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Center for Cancer Research, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden.
Nilsson JA; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Center for Cancer Research, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden.

Melanoma Res ; 32(4): 241-248, 2022 08 01.

Article in En | MEDLINE | ID: mdl-34753889

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Melanoma, Experimental Limits: Animals Language: En Journal: Melanoma Res Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Suecia Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google